CMPR vs STE · P/E 8.2, rev $3.74B vs P/E 25, rev $5.46B
Cimpress NV (CMPR) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Cimpress NV (CMPR) is a specialty business services company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported CMPR revenue for 2026-06-30 was $3.74B. Net income was $95.9M. Revenue was up 9.8% from 2025-06-30 to 2026-06-30. CMPR currently screens at market cap $1.19B and trailing P/E 8.2.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
CMPR currently screens at market cap $1.19B and trailing P/E 8.2. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the CMPR and STE stock pages for the full models.
Not investment advice.